CBIO
Crescent Biopharma, Inc. Common Stock
stockNASDAQ
Market OpenNov 10, 2026 2:08:15 PM EST
13.64USD-0.073%(-0.01)78,786
CBIO Financials
In Q2 FY 2026 (ended ), Crescent Biopharma, Inc. Common Stock (CBIO) reported revenue of $0, net income of −$24.84M, operating cash flow of −$19.46M, and assets of $182.76M (filed ).
Loading financial statements…